The objectives of this study were identifying Asprosin and Gremlin 1 gene expression in pediatric with T1DM, to assess their potential for early T1DM prediction, and correlate these markers’ changes with the clinical, metabolic, and consequences of the disease. The gene discussed is GREM1; the disease is type 1 diabetes mellitus.